2726 related articles for article (PubMed ID: 8132736)
1. Suramin inhibits tumor cell cytotoxicity mediated through natural killer cells, lymphokine-activated killer cells, monocytes, and tumor necrosis factor.
LaPushin R; Totpal K; Higuchi M; Aggarwal BB
J Clin Immunol; 1994 Jan; 14(1):39-49. PubMed ID: 8132736
[TBL] [Abstract][Full Text] [Related]
2. Cellular cytotoxicity of human natural killer cells and lymphokine-activated killer cells against bladder carcinoma cell lines.
Wang MH; Flad HD; Böhle A; Chen YQ; Ulmer AJ
Immunol Lett; 1991 Mar; 27(3):191-7. PubMed ID: 2060970
[TBL] [Abstract][Full Text] [Related]
3. Effect of elevated temperature on cytotoxic effector cells.
Singh VK; Biswas S; Pandey CM; Agarwal SS
Pathobiology; 1996; 64(3):150-5. PubMed ID: 8910924
[TBL] [Abstract][Full Text] [Related]
4. An acidic microenvironment inhibits antitumoral non-major histocompatibility complex-restricted cytotoxicity: implications for cancer immunotherapy.
Fischer B; Müller B; Fisch P; Kreutz W
J Immunother; 2000; 23(2):196-207. PubMed ID: 10746546
[TBL] [Abstract][Full Text] [Related]
5. Human lymphokine-activated killer (LAK) cells: III. Effect of L-phenylalanine methyl ester on LAK cell activation from human peripheral blood mononuclear cells: possible protease involvement of monocytes, natural killer cells and LAK cells.
Leung KH
Cancer Immunol Immunother; 1991; 34(1):31-6. PubMed ID: 1760808
[TBL] [Abstract][Full Text] [Related]
6. Elevated prostaglandin E2 production by monocytes is responsible for the depressed levels of natural killer and lymphokine-activated killer cell function in patients with breast cancer.
Baxevanis CN; Reclos GJ; Gritzapis AD; Dedousis GV; Missitzis I; Papamichail M
Cancer; 1993 Jul; 72(2):491-501. PubMed ID: 8319179
[TBL] [Abstract][Full Text] [Related]
7. Intracellular calcium changes associated with in vitro lymphokine-activated killer and natural killer cell cytotoxicity.
Burkey BB; Omann GM; Wolf GT
Arch Otolaryngol Head Neck Surg; 1991 Nov; 117(11):1281-6. PubMed ID: 1747234
[TBL] [Abstract][Full Text] [Related]
8. LAK-cell-mediated cytotoxicity against tumor cell targets used to monitor the stimulatory effect of interleukin-2: cytotoxicity, target recognition and phenotype of effector cells lysing the Daudi, T24 and K562 tumor cell lines.
Hermann GG; Zeuthen J; Claësson MH
Nat Immun; 1992; 11(1):7-16. PubMed ID: 1611282
[TBL] [Abstract][Full Text] [Related]
9. Influence of elevated temperature on natural killer cell activity, lymphokine-activated killer cell activity and lectin-dependent cytotoxicity of human umbilical cord blood and adult blood cells.
Shen RN; Lu L; Young P; Shidnia H; Hornback NB; Broxmeyer HE
Int J Radiat Oncol Biol Phys; 1994 Jul; 29(4):821-6. PubMed ID: 8040029
[TBL] [Abstract][Full Text] [Related]
10. Leukoregulin up-regulation of tumor cell sensitivity to natural killer and lymphokine-activated killer cell cytotoxicity.
Furbert-Harris PM; Evans CH
Cancer Immunol Immunother; 1989; 30(2):86-91. PubMed ID: 2688871
[TBL] [Abstract][Full Text] [Related]
11. Induction of bacillus-Calmette-Guérin-activated killer cells from human peripheral blood mononuclear cells against human bladder carcinoma cell lines in vitro.
Thanhäuser A; Böhle A; Flad HD; Ernst M; Mattern T; Ulmer AJ
Cancer Immunol Immunother; 1993 Jul; 37(2):105-11. PubMed ID: 8319241
[TBL] [Abstract][Full Text] [Related]
12. Heat-shock proteins protect cells from monocyte cytotoxicity: possible mechanism of self-protection.
Jäättelä M; Wissing D
J Exp Med; 1993 Jan; 177(1):231-6. PubMed ID: 8418204
[TBL] [Abstract][Full Text] [Related]
13. Lymphokine-activated killer-cell-mediated killing of WiDr colon carcinoma cells is inhibited by K562 erythroleukemia cells.
Dullens HF; Wind JC; Maas RA; Bernsen MR; Vulto IM; Rademakers LH; Den Otter W
Int Immunol; 1991 Oct; 3(10):959-64. PubMed ID: 1756146
[TBL] [Abstract][Full Text] [Related]
14. A Viscum album oligosaccharide activating human natural cytotoxicity is an interferon gamma inducer.
Mueller EA; Anderer FA
Cancer Immunol Immunother; 1990; 32(4):221-7. PubMed ID: 2124513
[TBL] [Abstract][Full Text] [Related]
15. Synergy of tumor necrosis factor and interleukin 2 in the activation of human cytotoxic lymphocytes: effect of tumor necrosis factor alpha and interleukin 2 in the generation of human lymphokine-activated killer cell cytotoxicity.
Owen-Schaub LB; Gutterman JU; Grimm EA
Cancer Res; 1988 Feb; 48(4):788-92. PubMed ID: 3257408
[TBL] [Abstract][Full Text] [Related]
16. Perforin, Fas ligand, and tumor necrosis factor are the major cytotoxic molecules used by lymphokine-activated killer cells.
Lee RK; Spielman J; Zhao DY; Olsen KJ; Podack ER
J Immunol; 1996 Sep; 157(5):1919-25. PubMed ID: 8757310
[TBL] [Abstract][Full Text] [Related]
17. Natural cytotoxicity of human blood monocytes and natural killer cells and their cytotoxic factors: discriminating effects of actinomycin D.
Uchida A; Klein E
Int J Cancer; 1985 May; 35(5):691-9. PubMed ID: 3997288
[TBL] [Abstract][Full Text] [Related]
18. Fibrin formation inhibits the in vitro cytotoxic activity of human natural and lymphokine-activated killer cells.
Gunji Y; Lewis J; Gorelik E
Blood Coagul Fibrinolysis; 1990 Dec; 1(6):663-72. PubMed ID: 2133246
[TBL] [Abstract][Full Text] [Related]
19. Autologous bone marrow purging by in situ IL-2 activation of endogenous killer cells.
Margolin KA; Wright C; Forman SJ
Leukemia; 1997 May; 11(5):723-8. PubMed ID: 9180298
[TBL] [Abstract][Full Text] [Related]
20. The induction of nitric oxide by interleukin-12 and tumor necrosis factor-alpha in human natural killer cells: relationship with the regulation of lytic activity.
Salvucci O; Kolb JP; Dugas B; Dugas N; Chouaib S
Blood; 1998 Sep; 92(6):2093-102. PubMed ID: 9731067
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
